Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9513225 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL14840420 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL2230600 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL5870603 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL14839987 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL23586497 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL14839929 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL19119422 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL10460520 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 | |
| SCHEMBL5511023 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230146515-A1 | MITOCHONDRIA-TARGETING PEPTIDES | STEALTH BIOTHERAPEUTICS INC. | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230146515-A1 | MITOCHONDRIA-TARGETING PEPTIDES | HSPE1, TFAM, TNNI3 | LMNA 2107/4885DNM1 141/4885ALDH1A1 3737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.